What the experiment compared
Researchers studied muscle cells, isolated mitochondria and rodents fed a high-fat diet. Berberine inhibited respiration through complex I, while experiments examined AMPK activation and a related derivative. [1]
The derivative showed metabolic effects in rodents. These observations concern experimental systems and cannot be directly converted into a safe or effective human supplement regimen. [1]
Interpretation and limits
Activating an energy-sensing pathway is not the same as producing more usable energy or improving fatigue. Funding and conflicts were not established from the abstract. Similarity to one drug mechanism also does not establish equivalence to that drug’s clinical effects. [1]
A hypothetical distinction
Imagine two compounds affect the same laboratory target. Their absorption, other targets, doses and clinical outcomes can still differ, so a shared target is not a treatment-equivalence test.
| Detail | Interpretation |
|---|---|
| Cells and rodents | Experimental models |
| Complex I and AMPK | Mechanistic findings |
| Human energy benefit | Not established |

Sources for this article
- Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.